FIELD: veterinary science.
SUBSTANCE: invention relates to veterinary medicine, particularly to veterinary obstetrics, and is intended for therapy of subclinical mastitis in lactating cows. On 1st, 2nd and 3rd days of treatment, a complex preparation based on aminoselentone containing bovine recombinant α- and γ-interferons with total activity of 1×104 IU/ml.
EFFECT: invention provides reducing the length of treatment of subclinical mastitis in lactating cows and increasing the effectiveness of treatment.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2016 |
|
RU2619862C1 |
METHOD FOR THE TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2022 |
|
RU2783249C1 |
METHOD FOR COMPLEX THERAPY OF MASTITIS IN LACTATING COWS | 2020 |
|
RU2756125C1 |
TREATMENT OF MASTITIS IN LACTATING COWS | 2022 |
|
RU2796986C1 |
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2013 |
|
RU2538721C1 |
METHOD OF PREVENTION MASTITIS OF LACTATING COWS | 2018 |
|
RU2683289C1 |
METHOD FOR PREVENTING POSTPARTUM ENDOMETRITIS IN COWS | 2020 |
|
RU2739697C1 |
METHOD FOR PREVENTING MASTITIS IN LACTATING COWS | 2019 |
|
RU2731476C1 |
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2010 |
|
RU2441660C1 |
PREVENTION OF MASTITIS IN LACTATING COWS | 2023 |
|
RU2804852C1 |
Authors
Dates
2022-03-24—Published
2021-07-26—Filed